BioAtla (BCAB) Net Equity Issued and Repurchased (2020 - 2026)
BioAtla's (BCAB) quarterly Net Equity Issued and Repurchased came in at $400000.0 in Q1 2026, up 109.98% quarter-over-quarter from -$4.0 million in Q4 2021.
BioAtla (BCAB) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
BioAtla's Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $400000.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn | - |
| 10 | BioAtla | 5.06 Mn | 5.06 Mn | - | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2021 | -4.01 Mn |
| Dec 31, 2021 | -4.01 Mn |
| Dec 31, 2020 | 68.18 Mn |
| Dec 31, 2020 | 68.18 Mn |